Evaluation of the Effect of Chicory Inulin-type Fructans in Constipated Adults
A Randomized Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of Chicory Inulin-type Fructans in Adults With Functional Constipation
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Constipation is common in the general population, especially in women and in the elderly, which can significantly affect quality of life of the individual. There is a general consumer trend to seek natural food options, also when addressing health issues such as constipation. Consumers seek tasty options and there is a paucity of tasty functional foods to address constipation. Adding natural fiber to food, like inulin-type fructans from chicory root fiber, can increase fiber intake and potentially prevent or resolve constipation issues. This study aimed to increase the body of scientific data on inulin-type fructans by way of a randomized, placebo-controlled, cross-over study. Maltodextrin was used as the placebo in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2016
CompletedFirst Submitted
Initial submission to the registry
June 28, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedJuly 7, 2022
July 1, 2022
9 months
June 28, 2022
July 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in stool frequency
Determine the impact of chicory inulin-type fructan on stool frequency in constipated subjects.
During the 12 week intervention period
Secondary Outcomes (6)
Change in stool consistency
During the 12 week intervention period
Patient Assessment of Constipation Symptoms
During the 12 week intervention period
Quality of life using the PAC-QOL questionnaire
During the 12 week intervention period
Physical activity
During the 12 week intervention period
Resort to laxatives
During the 12 week intervention period
- +1 more secondary outcomes
Study Arms (2)
Chicory inulin-type fructan - placebo
EXPERIMENTALDietary supplement: chicory inulin-type fructan Placebo: maltodextrin
Placebo - chicory inulin-type fructan
EXPERIMENTALPlacebo: maltodextrin Dietary Supplement: chicory inulin-type fructan
Interventions
Dietary supplement: chicory inulin-type fructan
Eligibility Criteria
You may qualify if:
- Able to give written informed consent
- Between 18 and 75 years of age
- Have functional constipation according to the Rome III Diagnostic Criteria
- Subjects were to continue on their normal diet and agreed to not take probiotic or prebiotic products/supplements and supplemental dietary fibres for the duration of the study
- The subject agrees to complete the Patient Diary for two weeks prior to study entry and for the duration of the study
- Subject is in general good health as determined by the investigator.
You may not qualify if:
- Subjects less than 18 and greater than 75 years of age
- Females who are pregnant, lactating or wish to become pregnant during the study.
- Subjects who are hypersensitive to any of the components of the test product,
- Subjects who have an obstructive or metabolic aetiology for constipation,
- Subjects who have a history of laxative abuse (greater than the daily dosage recommended on the label for any laxative),
- Subjects currently taking supplemental dietary fibres or have taken them within two weeks of the screening visit,
- Subjects who are taking a probiotic or prebiotic product/supplement or had taken them within two weeks of the screening visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sensuslead
- Atlantia Food Clinical Trialscollaborator
- Wageningen Universitycollaborator
Related Publications (1)
Puhlmann ML, Wegh CAM, van der Zalm SCC, Dam V, Doolan A, Meyer D, Belzer C, Vaughan EE, Benninga MA, Smidt H. Inulin-induced improvements on bowel habit and gut microbiota in adults with functional constipation: findings of a randomized, double-blind, placebo-controlled study. BMC Gastroenterol. 2025 Nov 13;25(1):806. doi: 10.1186/s12876-025-04409-6.
PMID: 41233756DERIVED
Study Officials
- STUDY CHAIR
Elaine E Vaughan, PhD
Sensus BV
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Subjects were blinded to the study treatment that they received
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2022
First Posted
July 7, 2022
Study Start
November 11, 2015
Primary Completion
July 28, 2016
Study Completion
July 28, 2016
Last Updated
July 7, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share